近畿大学奈良病院は、奈良県生駒市にある大学病院。地域がん診療連携拠点病院や災害拠点病院などの指定を受けている。

During the past decade, Kindai University Nara Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kindai University Nara Hospital" are "Alagille Syndrome (ALGS)" (1 trials) and "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials). Many other conditions were trialed in "Kindai University Nara Hospital" in a lesser frequency.

Most popular intervention types in "Kindai University Nara Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (1 trials), "Irinotecan" (1 trials), "Paclitaxel" (1 trials), "TAK-625" (1 trials) and "Tislelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kindai University Nara Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kindai University Nara Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kindai University Nara Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kindai University Nara Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".